Trademark: 97107538
Word
AMYRIAD THERAPEUTICS
Status Date
Friday, October 13, 2023
Filing Date
Wednesday, November 3, 2021
5 Pharmaceuticals, namely, pharmaceutical preparations to treat neurodegenerative diseases; pharmaceuticals, namely, pharmaceutical preparations to attenuate the accumulation of dysfunctional proteins
42 Scientific research services; medical research services; pharmaceutical research and development services; scientific research in the nature of conducting clinical trials in the field of neurodegenerative diseases; scientific research in the nature of conducting clinical trials in the field of dysfunctional protein accumulation; research and development in the field of biotechnology; research and development in the field of biochemistry; information, advisory and consultancy services in relation to all of the foregoing
Nov 6, 2021
New Application Entered
Nov 15, 2021
New Application Office Supplied Data Entered
Aug 12, 2022
Assigned To Examiner
Aug 19, 2022
Non-Final Action Written
Aug 19, 2022
Non-Final Action E-Mailed
Aug 19, 2022
Notification Of Non-Final Action E-Mailed
Feb 17, 2023
Teas Response To Office Action Received
Feb 17, 2023
Correspondence Received In Law Office
Feb 18, 2023
Teas/Email Correspondence Entered
Feb 27, 2023
Suspension Letter Written
Feb 27, 2023
Letter Of Suspension E-Mailed
Feb 27, 2023
Notification Of Letter Of Suspension E-Mailed
Oct 13, 2023
Report Completed Suspension Check Case Still Suspended
Jan 12, 2024
Assigned To Examiner
Apr 15, 2024
Suspension Checked - To Attorney For Action
Trademark Alertz updated from USPTO on 2030-01-24
